LabPulse.com staff writers

Trends and Finance
Lagging claims payment disputes with providers to cost Anthem $8.5M
The California Department of Managed Health Care has fined Anthem Blue Cross $8.5 million for failing to address claims payment disputes in a timely manner from doctors, hospitals, and other healthcare providers.
October 1, 2024
Claim Denied Form
PCR
Qiagen launches clinical oncology testing system
Qiagen
Qiagen has expanded its digital polymerase chain reaction portfolio and plans to enter the clinical testing space in North America and the European Union.
October 1, 2024
Test Tubes Social (2)
Emerging Technology
Geneoscopy adds N.Y. state lab permit for wider ColoSense testing
Noninvasive colorectal cancer screening test developer Geneoscopy has received a laboratory permit from the New York State Department of Health.
October 1, 2024
Colorectal Cancer Social (1)
Emerging Technology
CRISPR patent decisions could trigger waves globally
Canceling a pair of patents in Europe will affect a broad network of biotech companies that have bought and sold the rights to pursue gene-slicing research, according to a September 25 report published in MIT Technology Review.
September 30, 2024
Crispr Cas9 Gene Editing
Research Alliance
Owlstone, FDA's OSEL partner to develop VOC ID methods
Owlstone Medical entered a research collaboration agreement with the FDA's Center for Devices and Radiological Health Office of Science and Engineering Laboratories (OSEL) to develop methods of identifying volatile organic compounds (VOCs) in breath.
September 30, 2024
Molecule Social
Lawsuit
Lab manager, employees, sales reps on hook in $7.2M whistleblower fraud case
Settlements reveal the consequences of clinical laboratory tests used for nonmedical purposes.
September 27, 2024
Gavel Money Social
PCR
Roche launches diagnostic test for 12 respiratory viruses
Roche Diagnostics has launched its first test using its new high-throughput technology that enables users of Roche's Cobas analyzers to simultaneously test for 12 respiratory viruses.
September 26, 2024
Roche Aacc 2019 Social
Research Alliance
Cepheid partners with Fleming Initiative on antimicrobial resistance
Diagnostics firm Cepheid has entered a partnership with the Fleming Initiative, a global collaboration established by the Imperial College Healthcare National Health Service Trust and Imperial College London to combat antimicrobial resistance.
September 26, 2024
Colorized scanning electron micrograph of methicillin-resistant Staphylococcus aureus (MRSA) bacteria (gold) interacting with a human neutrophil (red). Image captured at NIAID's Rocky Mountain Laboratories (RML) in Hamilton, Montana.
Pathology and AI
Ibex survey indicates some comfort with AI in cancer diagnostics
A recent survey reports that more than 50% of U.S. adults have received an incorrect medical test result for themselves or a loved one. Additionally, 60% would trust artificial intelligence (AI) supporting medical diagnoses.
September 25, 2024
Doctor Patient Consult
Collaboration
Bio-Rad, Sysmex America partner for QC in hemostasis systems
Bio-Rad Laboratories and diagnostic test firm Sysmex America have formed a partnership in which Bio-Rad's Unity Next Peer QC software is offered with the Sysmex CA-Series and CS-Series hemostasis systems for coagulation testing.
September 24, 2024
Quality Check Mark Social
Previous Page
Page 2 of 361
Next Page
Top Stories
Proscia Embeddings
Artificial Intelligence
Proscia launches pathology AI model toolkit
Proscia has launched Concentriq Embeddings for experimenting with multiple pathology artificial intelligence (AI) models in parallel.
Crispr Cas9 Gene Editing
Emerging Technology
CRISPR patent decisions could trigger waves globally
Doctor Patient Consult
Pathology and AI
Ibex survey indicates some comfort with AI in cancer diagnostics
Olfactory Bulb Brain Cr Social
Pathology and AI
Pathologists detect microplastics in human brain tissue
Body composition in patients treated with Ozempic
Sponsor Content
Body composition in patients treated with Ozempic
More in Home
European Court rules for Illumina in jurisdictional appeal
By LabPulse.com staff writers
The European Court of Justice ruled that the European Commission did not have jurisdiction over Illumina's acquisition of Grail, reversing a ruling by a lower court that dismissed Illumina's appeal and overturning a €432 million ($477.8 million) fine.
September 4, 2024
Law Books Gavel Social
BioMarin to lay off 225 employees, reorganize programs
By LabPulse.com staff writers
BioMarin Pharmaceutical will lay off 225 employees as part of a reorganization, according to a regulatory form the company filed with the U.S. Securities and Exchange Commission.
August 30, 2024
Layoff Form Sign Social
CDC prioritizes mpox specimens for testing laboratories
By LabPulse.com staff writers
The CDC recommended that all laboratories performing mpox testing send certain types of clinical specimens to a laboratory that can perform clade-specific testing as quickly as possible.
August 28, 2024
Monkeypox Virus Social
University of Eastern Finland researchers develop algorithm for better breast cancer screening
By LabPulse.com staff writers
Researchers at the University of Eastern Finland have developed an algorithm to improve mammogram density assessment, with the potential to increase screening accuracy.
August 23, 2024
Breast Mammo Social
FDA issues draft guidance for PCCPs for medical devices
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has issued a draft guidance document for its proposed policies for predetermined change control plans (PCCPs) for medical devices.
August 23, 2024
Fda Sign Dc Social
Roche announces support for mpox response
By LabPulse.com staff writers
Roche is supporting the response to the global mpox health emergency by providing increased access to polymerase chain reaction (PCR) testing and partnering with governments, healthcare providers, and organizations to combat the mpox outbreak.
August 21, 2024
Monkeypox Virus Social
AMP sues FDA over LDT final rule, suggests CLIA reform
By LabPulse.com staff writers
AMP's lawsuit is one of a string of protests to the FDA's final rule on LDTs announced April 29, 2024.
August 20, 2024
Lawsuit Social
At-home heart failure screening device unveiled at ACS meeting
By LabPulse.com staff writers
A prototype heart-failure screening device that measures levels of two biomarkers for heart failure in as little as 15 minutes from a drop of saliva is being presented at the American Chemical Society (ACS) hybrid fall meeting.
August 20, 2024
Heart Pulmonary Trunk Social
Scale Bio launches 100M cell challenge research initiative
By LabPulse.com staff writers
Scale Biosciences, in collaboration with Ultima Genomics and Nvidia, has launched a global initiative for single-cell research projects aimed at collectively analyzing 100 million cells or more across diverse biological systems and research areas.
August 19, 2024
Single Cell Analysis Social
EnPlusOne, Wyss Institute collaborate on disease-agnostic RNA therapeutic
By LabPulse.com staff writers
EnPlusOne Biosciences and the Wyss Institute are collaborating on a research initiative to develop a rapid, effectively deployable disease-agnostic RNA therapeutic.
August 16, 2024
Rna Strand Social
Tulane advances digital microscopy imaging system
By LabPulse.com staff writers
The bedside scanning device could eventually enable slide-free pathology.
August 14, 2024
Tulane Tissue Scanner Cancer Left Behind 2024 Grant
Enzo takes $4.5M hit for lab data breach enabled by cybersecurity deficiencies
By LabPulse.com staff writers
Lab testing company's vulnerabilities cited as contributing to 2023 attack exposing health information of millions.
August 14, 2024
Data Network Breach Social
Previous Page
Page 2 of 125
Next Page